BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23227539)

  • 21. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
    Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
    Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanosuspensions: a promising drug delivery strategy.
    Patravale VB; Date AA; Kulkarni RM
    J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
    Kipp JE
    Int J Pharm; 2004 Oct; 284(1-2):109-22. PubMed ID: 15454302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development Considerations for Nanocrystal Drug Products.
    Chen ML; John M; Lee SL; Tyner KM
    AAPS J; 2017 May; 19(3):642-651. PubMed ID: 28281194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology controlled drug delivery for treating bone diseases.
    Yang L; Webster TJ
    Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid-in-oil dispersion: a novel core technology for drug delivery systems.
    Tahara Y; Kamiya N; Goto M
    Int J Pharm; 2012 Nov; 438(1-2):249-57. PubMed ID: 22975308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in the development of crystallized proteins as drug delivery system].
    Shi K; Jiang YB; Yang LL; Cui FD
    Yao Xue Xue Bao; 2009 Aug; 44(8):845-51. PubMed ID: 20055150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanocrystals based mucosal delivery system: research advances.
    Liu Y; Shuai S; Huang G; Chen Y; Shen B; Yue P
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1700-1712. PubMed ID: 35287534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug nanoparticles: formulating poorly water-soluble compounds.
    Merisko-Liversidge EM; Liversidge GG
    Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic micro- and nano-particle-based targeting for drug and gene delivery.
    Dobson J
    Nanomedicine (Lond); 2006 Jun; 1(1):31-7. PubMed ID: 17716207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
    Kumar S; Randhawa JK
    Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical and chemical stability of drug nanoparticles.
    Wu L; Zhang J; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in the development of stabilization strategies for nanocrystal preparations.
    Li J; Wang Z; Zhang H; Gao J; Zheng A
    Drug Deliv; 2021 Dec; 28(1):19-36. PubMed ID: 33336609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patents on nanoparticulate drug delivery systems--a review.
    Bhavna ; Ali M; Baboota S; Ali J
    Recent Pat Drug Deliv Formul; 2008; 2(1):83-9. PubMed ID: 19075900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.